RemeGen Co., Ltd. (OTCMKTS:REGMF) Short Interest Down 42.3% in March

RemeGen Co., Ltd. (OTCMKTS:REGMF) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 196,500 shares, a drop of 42.3% from the February 28th total of 340,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

RemeGen Stock Performance

Shares of OTCMKTS REGMF remained flat at $1.50 during midday trading on Friday. The stock had a trading volume of 50,000 shares, compared to its average volume of 550. RemeGen has a 12 month low of $1.50 and a 12 month high of $4.00. The company’s 50 day simple moving average is $1.50 and its two-hundred day simple moving average is $1.52.

About RemeGen

RemeGen Co, Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers.